New Draft Guidance on Remote Regulatory Assessments

On July 22, the FDA published a draft guidance on conducting Remote Regulatory Assessments. Remote Regulatory Assessments (RRAs) were originally developed during the COVID-19 health emergency and are a set of tools to help the Agency conduct oversight, mitigate risk, and meet critical public health needs with respect to certain FDA-regulated products. Currently, requests for... Continue Reading